Home / Companies / AstraZeneca PLC / 9 Apr 2026
AstraZeneca PLC: meeting of 9 Apr 2026
Votes reported on Form N-PX, item by item
934 Form N-PX filers reported votes at the AstraZeneca PLC meeting of 9 Apr 2026. Their records fall into 10 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
13 nominees; 75.8% of reported votes for; 122 filers withheld from or voted against at least one nominee.
18,112 vote records from 448 filers. 1 of the 443 filers that marked the item either way voted against management. 5 filers reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
933 vote records from 577 filers. 5 of the 553 filers that marked the item either way voted against management. 24 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
2,790 vote records from 446 filers. 0 of the 440 filers that marked the item either way voted against management. 6 filers reported this item without a management mark.
SHAREHOLDER RIGHTS AND DEFENSESIssuer
SHAREHOLDER RIGHTS AND DEFENSES: management items
Management items in this category are shown together; filers word and number them differently.
111 vote records from 35 filers. 0 of the 35 filers that marked the item either way voted against management.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
6,232 vote records from 446 filers. 1 of the 440 filers that marked the item either way voted against management. 6 filers reported this item without a management mark.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
1,870 vote records from 445 filers. 1 of the 439 filers that marked the item either way voted against management. 6 filers reported this item without a management mark.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
3,820 vote records from 442 filers. 1 of the 436 filers that marked the item either way voted against management. 6 filers reported this item without a management mark.
OTHER SOCIAL ISSUESIssuer
OTHER SOCIAL ISSUES: management items
Management items in this category are shown together; filers word and number them differently.
1,030 vote records from 435 filers. 4 of the 430 filers that marked the item either way voted against management. 5 filers reported this item without a management mark.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
186 vote records from 73 filers. 0 of the 70 filers that marked the item either way voted against management. 3 filers reported this item without a management mark.
Several categoriesSecurity holder
Shareholder proposals (not separable from the filings)
Filers described these proposals in wordings that could not be matched to one another, so they are shown together.
12 vote records from 1 filers. 0 of the 1 filers that marked the item either way voted against management.
How the largest families voted
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the AstraZeneca PLC meeting?
934 Form N-PX filers reported votes at the meeting of 9 Apr 2026. On say-on-pay, 5 of 553 voted against management (0.9%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by AstraZeneca PLC on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for AstraZeneca PLC
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing AstraZeneca PLC with a meeting date within three days of 9 Apr 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.